1659TiP A Spanish observational study for MOLecular characterization of THYroid carcinoma: MOLTHY Project – TTCC-2020-02

Thyroid cancer (TC) is the most frequent endocrine cancer. Treatment is generally based on surgery +/- radioactive iodine (RAI) and TSH suppression in Differentiated TC (DTC) and surgery and levothyroxine suppression in Medullary TC (MTC). Multiple kinase inhibitor drugs have become the standard therapy for advanced TC. New molecular-driven alterations therapies have raised such as neurotrophic tyrosine kinase receptor (NTRK) and rearranged during transfection (RET) inhibitors. The availability of molecular profiling test at cancer centers provides precision medicine in clinical routine and new treatment opportunities.